| [1] | Association of American Medical Colleges (2008) Industry funding of medical education: report of an AAMC task force, June 2008. Available: https://services.aamc.org/Publications/s？howfile.cfm?file=version114.pdf&prd_id=2？32&prv_id=281&pdf_id=114. Accessed 8 May 2009.
|
| [2] | Greenland P (2009) Time for the medical profession to act. Arch Intern Med 169: 829–831.
|
| [3] | Harris G (2008 October 4) Top psychiatrist didn't report drug maker's pay. New York Times; A1.
|
| [4] | Rothman DJ, Chimonas S (2008) New developments in managing physician-industry relationships. JAMA 300: 1067–1069.
|
| [5] | Ross JR, Lackner JE, Lurie P, Gross CP, Wolfe S, et al. (2007) Pharmaceutical company payments to physicians. JAMA 297: 1216–1223.
|
| [6] | (2009) Senate Bill S.301. Physician Payments Sunshine Act of 2009. Available: http://thomas.loc.gov/cgi-bin/bdquery/D?？d111:3:./temp/~bdhqHM:L&summ2=m&/bss/111？search.html. Accessed 13 May 2009.
|
| [7] | (2008) House of Representatives Bill H.R.5605. Physician Payments Sunshine Act of 2008. Available: http://thomas.loc.gov/cgi-bin/query/D?c1？10:9:./temp/~c110EAsKeZ. Accessed 13 May 2009.
|
| [8] | Medicines Australia (2009) Educational Event Reports. Available: http://www.medicinesaustralia.com.au/pag？es/page136.asp. Accessed 8 May 2009.
|
| [9] | Australian Competition and Consumer Commission (27 June 2007) Australian competition tribunal affirms ACCC's decision on extra reporting for Medicines Australia Code. Press release number MR 163/07. Available: http://www.accc.gov.au/content/index.pht？ml/itemId/790845/fromItemId/621589?pageD？efinitionItemId=16940. Accessed 8 May 2009.
|
| [10] | Medicines Australia (28 March 2008) Medicines Australia sets world-first in transparency. Press release. Available: http://www.medicinesaustralia.com.au/pag？es/images/MR%20Mar%202803%20MA%20sets%20？precedent65.pdf. Accessed 13 May 2009.
|
| [11] | Medicines Australia (2009) Glossary - educational event report table contents. Available: http://www.medicinesaustralia.com.au/pag？es/page144.asp. Accessed 8 May 2009.
|
| [12] | Medicines Australia.Member company reports, and non-member company reports, 1 July–31 December 2007. Member reports: Available: http://www.medicinesaustralia.com.au/pag？es/page230.asp; Nonmember reports: Available: http://www.medicinesaustralia.com.au/pag？es/page500.asp. Accessed 8 May 2009.
|
| [13] | Wazana A (2000) Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 283: 373–380.
|
| [14] | Steinman MA, Harper GM, Chren MM, Landefeld CS, Bero LA (2007) Characteristics and impact of drug detailing for gabapentin. PLoS Med 4: e134. doi:10.1371/journal.pmed.0040134.
|
| [15] | Hemminki E, Karttunen T, Hovi SL, Karro H (2004) The drug industry and medical practice – the case of menopausal hormone therapy in Estonia. Soc Sci Med 58: 89–97.
|
| [16] | Ross JS, Nazem AG, Lurie P, Lackner JE, Krumholz HM (2008) Updated estimates of pharmaceutical company payments to physicians in Vermont. JAMA 300: 1998–2000.
|
| [17] | Katz D, Caplan AL, Merz JF (2003) All gifts large and small. Am J Bioeth 3: 39–46.
|
| [18] | Gagnon MA, Lexchin J (2008) The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med 5: e1. doi:10.1371/journal.pmed.0050001.
|
| [19] | Norris P, Herxheimer A, Lexchin J, Mansfield P (2005) Drug promotion: what we know, what we have yet to learn. Geneva: World Health Organization. Available: http://www.who.int/entity/medicines/area？s/rational_use/drugPromodhai.pdf. Accessed 13 May 2009.
|
| [20] | Blumenthal D (2004) Doctors and drug companies. N Engl J Med 351: 1885–1890.
|
| [21] | Institute of Medicine (2009) Policies on conflict of interest: Overview and evidence. In: Lo B, Field MJ, editors. Conflict of interest in medical research, education, and practice. Washington (D.C.): The National Academies Press. pp. 51–78.
|
| [22] | Bero L, Krughoff R, Loewenstein G (2009) Appendix F: Model for broader disclosure. In: Lo B, Field MJ, editors. Conflict of interest in medical research, education, and practice. Washington (D.C.): The National Academies Press. pp. 325–330.
|
| [23] | Medicines Australia (2008) Code of Conduct Annual Report 2008. Available: http://www.medicinesaustralia.com.au/pag？es/images/Code-of-Conduct-2008-Annual-Re？port.pdf. Accessed 8 May 2009.
|
